- $26.28bn
- $27.65bn
- CA$14.30bn
- 98
- 48
- 81
- 89
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12,111 | 12,164 | 12,127 | 12,867 | 14,296 |
Cost of Revenue | |||||
Gross Profit | 10,914 | 10,622 | 10,646 | 11,447 | 12,806 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10,434 | 10,648 | 10,289 | 10,900 | 12,098 |
Operating Profit | 1,677 | 1,516 | 1,838 | 1,967 | 2,198 |
Net Income Before Taxes | 1,677 | 1,516 | 1,838 | 1,967 | 2,198 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,263 | 1,118 | 1,369 | 1,466 | 1,631 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,263 | 1,118 | 1,369 | 1,466 | 1,631 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,263 | 1,118 | 1,369 | 1,466 | 1,631 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.76 | 4.89 | 5.48 | 6.15 | 7.06 |